Treatment of alzheimer's disease and modulation of immune...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/565 (2006.01)

Patent

CA 2141436

Alzheimer's disease and immune deficiency disorders may be effectively treated by administering a therapeutic amount of a .DELTA.5-Androstene-3.beta.-ol-17-one having a C7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis.

Il est possible de traiter efficacement la maladie d'Alzheimer et des troubles d'immunodéficience en administrant en une dose thérapeutique, une DELTA5-androstène-3beta-ol-17-one présentant un substituant C7 choisi dans le groupe composé d'oxo, d'hydroxy et de groupes qui y sont convertibles par hydrolyse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of alzheimer's disease and modulation of immune... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of alzheimer's disease and modulation of immune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of alzheimer's disease and modulation of immune... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1972312

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.